Cargando…
1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016
BACKGROUND: The threat of medical liability can influence physician behavior and lead to the practice of “defensive medicine.” Concern for malpractice liability has been cited as a cause of inappropriate antibiotic prescribing. Data on malpractice claims related to antibiotic use (AU) are lacking. T...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810467/ http://dx.doi.org/10.1093/ofid/ofz360.1499 |
_version_ | 1783462262806151168 |
---|---|
author | Kabbani, Sarah Greenberg, Penny Falcone, Bianca DeRoo, Courtney Yu-Moe, C Winnie Srinivasan, Arjun Hicks, Lauri |
author_facet | Kabbani, Sarah Greenberg, Penny Falcone, Bianca DeRoo, Courtney Yu-Moe, C Winnie Srinivasan, Arjun Hicks, Lauri |
author_sort | Kabbani, Sarah |
collection | PubMed |
description | BACKGROUND: The threat of medical liability can influence physician behavior and lead to the practice of “defensive medicine.” Concern for malpractice liability has been cited as a cause of inappropriate antibiotic prescribing. Data on malpractice claims related to antibiotic use (AU) are lacking. The objectives of this analysis were to describe malpractice claims associated with AU. METHODS: We conducted a retrospective analysis of pooled closed antibiotic-related claims from a malpractice carrier representing 30% of US malpractice cases from January, 2007 to December, 2016. We described antibiotic-related, malpractice claims, patient demographics, amount of indemnity paid, clinical severity, settings, responsible services, initial diagnoses, drug classes, and causes of allegation. RESULTS: From 2007 to 2016, 767 antibiotic-related claims were identified and represented less than 1% of overall claims. A total of $123 million were paid for antibiotic-related claims. Claims classified as medium to high clinical severity constituted 97% of all claims, with 35% having permanent injury and 24% leading to death. Of all patients, 56% were female, 8% were < 20 years of age, and 32% were ≥ 60 years old. Most claims (51%) were associated with outpatient settings, 37% with inpatient, and 11% with emergency department settings. Responsible services with the highest number of claims were medicine (44%), surgery (27%) and the emergency medicine (9%). The most common infection cited as an initial diagnosis was respiratory (10%), followed by urinary (7%) and skin and soft-tissue infections (6%). The most common class cited was β-lactams (19%), followed by fluoroquinolones (14%) and sulfa-drugs (11%). Allegations associated with antibiotic administration and management constituted 62% of all claims, 19% were related to failure or delay in diagnosis or treatment, and 19% were due to other causes. CONCLUSION: Claims related to AU were not a common cause of malpractice claims in these data source. Antibiotic administration and management was more commonly associated with malpractice claims than failure or delay in AU. A better understanding of malpractice claims associated with AU can help guide messaging on improving antibiotic prescribing. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68104672019-10-28 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 Kabbani, Sarah Greenberg, Penny Falcone, Bianca DeRoo, Courtney Yu-Moe, C Winnie Srinivasan, Arjun Hicks, Lauri Open Forum Infect Dis Abstracts BACKGROUND: The threat of medical liability can influence physician behavior and lead to the practice of “defensive medicine.” Concern for malpractice liability has been cited as a cause of inappropriate antibiotic prescribing. Data on malpractice claims related to antibiotic use (AU) are lacking. The objectives of this analysis were to describe malpractice claims associated with AU. METHODS: We conducted a retrospective analysis of pooled closed antibiotic-related claims from a malpractice carrier representing 30% of US malpractice cases from January, 2007 to December, 2016. We described antibiotic-related, malpractice claims, patient demographics, amount of indemnity paid, clinical severity, settings, responsible services, initial diagnoses, drug classes, and causes of allegation. RESULTS: From 2007 to 2016, 767 antibiotic-related claims were identified and represented less than 1% of overall claims. A total of $123 million were paid for antibiotic-related claims. Claims classified as medium to high clinical severity constituted 97% of all claims, with 35% having permanent injury and 24% leading to death. Of all patients, 56% were female, 8% were < 20 years of age, and 32% were ≥ 60 years old. Most claims (51%) were associated with outpatient settings, 37% with inpatient, and 11% with emergency department settings. Responsible services with the highest number of claims were medicine (44%), surgery (27%) and the emergency medicine (9%). The most common infection cited as an initial diagnosis was respiratory (10%), followed by urinary (7%) and skin and soft-tissue infections (6%). The most common class cited was β-lactams (19%), followed by fluoroquinolones (14%) and sulfa-drugs (11%). Allegations associated with antibiotic administration and management constituted 62% of all claims, 19% were related to failure or delay in diagnosis or treatment, and 19% were due to other causes. CONCLUSION: Claims related to AU were not a common cause of malpractice claims in these data source. Antibiotic administration and management was more commonly associated with malpractice claims than failure or delay in AU. A better understanding of malpractice claims associated with AU can help guide messaging on improving antibiotic prescribing. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810467/ http://dx.doi.org/10.1093/ofid/ofz360.1499 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Kabbani, Sarah Greenberg, Penny Falcone, Bianca DeRoo, Courtney Yu-Moe, C Winnie Srinivasan, Arjun Hicks, Lauri 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title | 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title_full | 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title_fullStr | 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title_full_unstemmed | 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title_short | 1635. Analysis of Antibiotic-Related Malpractice Claims, 2007 to 2016 |
title_sort | 1635. analysis of antibiotic-related malpractice claims, 2007 to 2016 |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810467/ http://dx.doi.org/10.1093/ofid/ofz360.1499 |
work_keys_str_mv | AT kabbanisarah 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT greenbergpenny 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT falconebianca 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT deroocourtney 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT yumoecwinnie 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT srinivasanarjun 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 AT hickslauri 1635analysisofantibioticrelatedmalpracticeclaims2007to2016 |